Medexus Pharmaceuticals Inc (TSE:MDP)
TSX:MDP
Holding TSE:MDP?
Track your performance easily

Medexus Pharmaceuticals Inc (MDP) Financial Statements

41 Followers

Medexus Pharmaceuticals Inc Financial Overview

Medexus Pharmaceuticals Inc's market cap is currently ―. The company's EPS TTM is C$0.049; its P/E ratio is 49.50; Medexus Pharmaceuticals Inc is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is C$0.01. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 27.28M$ 25.96M$ 25.21M$ 30.33M$ 31.55M
Gross Profit$ 14.84M$ 13.30M$ 12.69M$ 16.28M$ 17.24M
EBIT$ 3.93M$ 3.21M$ 1.86M$ 3.26M$ 5.14M
EBITDA$ 5.34M$ 4.66M$ 3.31M$ 4.72M$ 6.58M
Net Income Common Stockholders$ 1.96M$ 762.00K$ -534.00K$ -1.09M$ 651.00K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 8.45M$ 5.25M$ 8.21M$ 19.50M$ 15.78M
Total Assets$ 147.26M$ 155.73M$ 160.38M$ 166.18M$ 166.87M
Total Debt$ 46.84M$ 49.90M$ 52.29M$ 72.09M$ 72.92M
Net Debt$ 38.38M$ 44.64M$ 44.08M$ 52.59M$ 57.14M
Total Liabilities$ 114.67M$ 125.41M$ 130.81M$ 144.44M$ 144.15M
Stockholders Equity$ 32.59M$ 30.32M$ 29.56M$ 21.74M$ 22.73M
Cash Flow-
Free Cash Flow$ 8.16M$ 1.39M--$ 4.19M
Operating Cash Flow$ 8.19M$ 1.61M$ 5.54M$ 7.35M$ 4.21M
Investing Cash Flow$ -477.00K$ -538.00K$ -1.75M$ -592.00K$ -597.00K
Financing Cash Flow$ -4.50M$ -3.96M$ -22.76M$ -2.96M$ -968.00K
Currency in USD

Medexus Pharmaceuticals Inc Earnings and Revenue History

Medexus Pharmaceuticals Inc Debt to Assets

Medexus Pharmaceuticals Inc Cash Flow

Medexus Pharmaceuticals Inc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis